3 patient evaluations for Buprenorphine-Naloxone

Sep 28, 2011 (Started Oct 15, 2010)

  • Effectiveness
    Major (for drug use disorder)
  • Effectiveness
    Slight (for major depressive disorder)
  • Side effects
    Mild
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Cost: $50-99 monthly

Sep 12, 2011 (Started Oct 15, 2010)

  • Effectiveness
    Major (for drug use disorder)
  • Effectiveness
    Slight (for major depressive disorder)
  • Side effects
    Moderate
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 1 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $50-99 monthly

Feb 1, 2011 (Started Oct 15, 2010)

  • Effectiveness
    Slight (for major depressive disorder)
  • Side effects
    Mild
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 8 mg-2 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $50-99 monthly

  • 0 helpful marks

Mar 1, 2009 (Started Mar 01, 2009)

  • Effectiveness
    Major (for Stops craving for opiates but works for pain)
  • Effectiveness
    Major (for fibromyalgia)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 3 x 8 mg-2 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

  • 1 helpful mark

Feb 10, 2009 (Started Aug 15, 2007)

  • Effectiveness
    Moderate (for back pain)
  • Side effects
    Mild (constipation, decreased sex drive (libido))
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 2 x 8 mg-2 mg Daily
Cost: $25-49 monthly
Side effects: constipation, decreased sex drive (libido), decreased sex drive (libido)

  • 0 helpful marks
Last updated:
Showing 3 of 3 patient evaluations for Buprenorphine-Naloxone